Sex-Based Outcomes of Darunavir–Ritonavir Therapy

Abstract
Women with HIV-1 infection are underrepresented in clinical trials of antiviral drugs for HIV treatment. In this trial of darunavir–ritonavir, treatment-experienced HIV-positive women were recruite... Background: Women account for an increasing proportion of patients with HIV-1 but remain underrepresented in antiretroviral clinical trials. Objective: To evaluate sex-based differences in efficacy...

This publication has 24 references indexed in Scilit: